Does Eliminating Coffee Avoid Fibrillation (DECAF) Trial
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
Summary
Caffeinated coffee may reduce the risk of atrial fibrillation through several proposed mechanisms, including improved autonomic balance, antioxidant effects, and enhanced vascular function. While observational data have hinted at these benefits, randomized trial evidence has been limited. Findings from the DECAF Trial further demonstrate that atrial fibrillation patients do not need to avoid caffeinated coffee—and that it may even help lower their risk of future episodes.
In this interview, Matthew W. Martinez MD, FACC and Gregory M. Marcus, MD, FACC discuss the 'Does Eliminating Coffee Avoid Fibrillation (DECAF)' Trial.
adbl_web_anon_alc_button_suppression_c
No reviews yet